Replies to post #6296 on Echo Therapeutics Inc fka ECTE

[USOB]

@Lintin
Very valid points. Echo is the only company to come closest to developing a noninvasive glucose device. If the Apple Watch will be void of "groundbreaking" technology, why not make a play for Echo's IP and parents? Apple certainly has the resources to develop ECTE's TCGM for the entire spectrum of glucose populations - critical care to outpatient to fitness.

It seems like a waste of the shareholders money to allow Echo's of technology and $100 of millions of R&D to dies on the vine.